Navigenics: On the market! April 8, 2008
Posted by Bertalan Meskó in Medicine.trackback
We’ve been all waiting for this. Navigenics is now officially on the market and launched its service. The main differencies between Navigenics and the other personalized genetic companies were described clearly in a recent Wired article:
- They cover 18 diseased and they’re using a 1 million SNP chip.
- They charge an initial fee of $2,500 for a one year membership and an annual fee of $250. But they re-test your DNA from time to time as more associations with different SNPs are discovered.
- They calculate Lifetime Risk instead of comparing my risk to the average one.
- 24/7 access to their genetic counselors.
- And they involve physicians strongly:
Navigenics puts a great deal of emphasis on the utility of genotype data for useful medical insights. To that end, “we’re putting education towards the top of our agenda,” says Mari Baker, and they’ve bankrolled an online continuing medical education course on Genomic and Personalized Medicine with Medscape. What’s more, they suggest customers bring doctors their Health Compass Report, a primer for personal physicians explaining what the company does, how it calculates risk, and what their patients results might precondition them for.
At this point, I’m impressed. We will see how it goes and when they will come to the European market.
Further reading:
[...] The launch is also mentioned in an exclusive interview at Genetics and Health with Navigenics’ medical director, Dr. Michael Nierenberg. This piece is the first article in a seven article series, including the future article 6, which discusses some of my favorite things: “Privacy, insurance, GINA, and ethics.” I’ll be sure to link to that article when it comes out. The launch is also discussed over at ScienceRoll. [...]
Berci,
Can you believe it? We have seen this garage outfit turn into an industry! We have the best seats in the house. I will let you know how SoHo goes. One thing is for sure…..we just got a whole bunch of new potential patients!
-Steve
http://www.helixhealth.org
[...] The past week was centered around Navigenics, the newest personalized genetic company. After I posted about the launch of the company, Hsien-Hsien Lei had an interview with Elissa Levin, the director of the [...]
[...] Navigenics: On the market! Possibly related posts: (automatically generated)Note your risk factors!23andMe: The Re-ReviewAAP Encourages Risk Assessment In EvaluationsMaking It To 90-Increase your odds [...]